AVNS Q3 2024 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$170M-0.5% YoY

Gross Profit

$93M54.5% margin

Operating Income

$17M9.8% margin

Net Income

$4M2.5% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$427M

Stockholders' Equity

$1.2B

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$170M	$171M	-0.5%
Gross Profit	$93M	$96M	-2.7%
Operating Income	$17M	$26M	-34.5%
Net Income	$4M	-$4M	+216.2%

Revenue Segments

Digestive Health

$98M70%

Interventional pain

$42M30%